Polymorphisms of Paraoxonase (PON1) and Their Significance in Clinical Toxicology of Organophosphates

REFERENCES

• Costa LG. The emerging field of ecogenetics. NeuroToxicology 2000; 21: 85–89
   PubMed Web of Science ®Google Scholar
• Mackness MI, Durrington PN, Mackness B. The role of paraoxonase in lipid metabolism. Paraoxonase (PON1) in Health and Disease: Basic and Clinical Aspects, LG Costa, CE Furlong. Kluwer Academic Publishers, Norwell, MA 2002; 79–92
   Google Scholar
• Shih DM, Reddy S, Lusis AJ. CHD and atherosclerosis: human epidemiological studies and transgenic mouse models. Paraoxonase (PON1) in Health and Disease: Basic and Clinical Aspects, LG Costa, CE Furlong. Kluwer Academic Publishers, Norwell, MA 2002; 93–123
   Google Scholar
• Furlong CE, Cole TB, Jarvik GP, Costa LG. Pharmacogenomic considerations of the paraoxonase polymorphisms. Pharmacogenomics 2002; 3: 1–8
   PubMed Web of Science ®Google Scholar
• La Du BN. Historical considerations. Paraoxonase (PON1) in Health and Disease: Basic and Clinical Aspects, LG Costa, CE Furlong. Kluwer Academic Publishers, Norwell, MA 2002; 1–25
   Google Scholar
• Lotti M. Organophosphorus compounds. Experimental and Clinical Neurotoxicology, PS Spencer, H Schaumburg, AC Ludolph. Oxford University Press, Oxford 2000; 898–925
   Google Scholar
• Lotti M. Low level exposures to organophosphorus esters and peripheral nerve function. Muscle Nerve 2002; 23: 492–504
   Web of Science ®Google Scholar
• Sogorb MA, Vilanova E. Enzyme involved in the detoxification of organophosphorus, carbamate and pyrethroid insecticides through hydrolysis. Toxicol Lett 2002; 128: 215–228
   PubMed Web of Science ®Google Scholar
• Geldmacher-von Mallinckrodt M, Diepgen TL. The human serum paraoxonase: polymorphism and specificity. Toxicol Environ Chem 1988; 18: 79–196
   Web of Science ®Google Scholar
• Brealey CB, Walker CH, Baldwin BC. A-esterase activities in relation to the differential toxicity of pirimiphos-methyl to birds and mammals. Pestic Sci 1980; 11: 546–554
   Google Scholar
• Costa LG, Richter RJ, Murphy SD, Omenn GS, Motulsky AG, Furlong CE. Species differences in serum paraoxonase correlate with sensitivity to paraoxon toxicity. Toxicology of Pesticides: Experimental, Clinical and Regulatory Perspectives, LG Costa, CL Galli, SD Murphy. Springer-Verlag, Heidelberg 1987; 262–266
   Google Scholar
• Main AR. The role of A-esterase in the acute toxicity of paraoxon, TEPP and parathion. Can J Biochem Physiol 1956; 34: 197–216
   PubMedGoogle Scholar
• Costa LG, McDonald BE, Murphy SD, Richter RJ, Motulsky AG, Furlong CE. Serum paraoxonase and its influence on paraoxon and chlorpyrifos oxon toxicity in rats. Toxicol Appl Pharmacol 1990; 103: 66–76
   PubMed Web of Science ®Google Scholar
• Li WF, Costa LG, Furlong CE. Serum paraoxonase status: a major factor in determining resistance to organophosphates. J Toxicol Environ Health 1993; 40: 337–346
   PubMed Web of Science ®Google Scholar
• Li WG, Furlong CE, Costa LG. Paraoxonase protects against chlorpyrifos toxicity in mice. Toxicol Lett 1995; 76: 219–226
   PubMed Web of Science ®Google Scholar
• Shih DM, Gu L, Xia YR, Navab M, Li WF, Hama S, Castellani LW, Furlong CE, Costa LG, Fogelman AM, Lusis AJ. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 1998; 394: 284–287
   PubMed Web of Science ®Google Scholar
• Li WF, Costa LG, Richter RJ, Hagen T, Shih DM, Tward A, Lusis AJ, Furlong CE. Catalytic efficiency determines the in vivo efficacy of PON1 for detoxifying organophosphates. Pharmacogenetics 2000; 10: 1–13
   Google Scholar
• Eckerson HW, White CM, La Du BN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 1983; 35: 1126–1138
   PubMed Web of Science ®Google Scholar
• Mueller RF, Hornung S, Furlong CE, Anderson J, Giblett ER, Motulsky AG. Plasma paraoxonase polymorphism: a new enzyme assay, population, family, biochemical and linkage studies. Am J Hum Genet 1983; 35: 393–408
   PubMed Web of Science ®Google Scholar
• Gan KN, Smolen Al, Eckerson HW, La Du BN. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos 1991; 19: 100–106
   PubMed Web of Science ®Google Scholar
• Furlong CE, Richter RJ, Chapline C, Crabb JW. Purification of rabbit and human serum paraoxonase. Biochemistry 1991; 30: 10133–10140
   PubMed Web of Science ®Google Scholar
• Hassett C, Richter RJ, Humbert R, Chapline C, Crabb JW, Omiecinski CJ, Furlong CE. Characterization of DNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence. Biochemistry 1991; 30: 10141–10149
   PubMed Web of Science ®Google Scholar
• Humbert R, Adler DA, Disteche CM, Hassett C, Omiecinski CJ, Furlong CE. The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet 1993; 3: 36–73–76
   PubMed Web of Science ®Google Scholar
• Adkins S, Gan KN, Mody M, La Du BN. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes. Am J Hum Genet 1993; 53: 598–608
   Google Scholar
• Brophy VH, Jarvik GP, Furlong CE. PON1 polymorphisms. Paraoxonase (PON1) in Health and Disease: Basic and Clinical Aspects, LG Costa, CE Furlong. Kluwer Academic Publishers, Norwell, MA 2002; 53–77
   Google Scholar
• Brophy VM, Hastings MD, Clendenning JB, Richter RJ, Jarvik GP, Furlong CE. Polymorphisms in the human paraoxonase (PON1) promoter. Pharmacogenetics 2001a; 11: 64–77–84
   Google Scholar
• Leviev I, James RW. Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations. Arterioscler Thromb Vasc Biol 2000; 20: 516–521
   PubMed Web of Science ®Google Scholar
• Suehiro T, Nakamura T, Inove M, Shiinoki T, Ikeda Y, Kumon Y, Shindo M, Tanaka H, Hashimoto K. A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression. Atherosclerosis 2000; 150: 295–298
   PubMed Web of Science ®Google Scholar
• Brophy VH, Jampsa RL, Clendenning JB, McKinstry LA, Furlong CE. Effects of 5′ regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. Am J Hum Genet 2001b; 68: 1428–1436
   PubMed Web of Science ®Google Scholar
• Blatter Garin MC, James RW, Dussoix P, Blanche M, Passa P, Froguel P, Ruiz J. Paraoxonase polymorphism Met-Leu 54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Investig 1997; 99: 62–66
   PubMed Web of Science ®Google Scholar
• Mackness B, Mackness MI, Arrol T, Turkie W, Durrington PN. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modifications. FEBS Lett 1998; 423: 57–60
   PubMed Web of Science ®Google Scholar
• Davies HG, Richter RJ, Keifer M, Broomfield CA, Sowalla J, Furlong CE. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat Genet 1996; 14: 334–336
   PubMed Web of Science ®Google Scholar
• Richter RJ, Furlong CE. Determination of paraoxonase (PON1) status require more then genotyping. Pharmacogenetics 1999; 9: 745–753
   PubMedGoogle Scholar
• Chambers JE, Ma T, Boone JS, Chambers HW. Role of detoxication pathways in acute toxicity levels of phosphorothioate insecticides in the rat. Life Sci 1994; 54: 1357–1364
   PubMed Web of Science ®Google Scholar
• Pond AL, Chambers HW, Chambers JE. Organophosphate detoxication potential of various rat tissues via A-esterases and aliesterase activities. Toxicol Lett 1995; 78: 245–252
   PubMed Web of Science ®Google Scholar
• Jarvik GP, Rozek LS, Brophy VH, Hatsukami TS, Richter RJ, Schellenberg GD, Furlong CE. Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1192 or PON155 genotype. Arterioscler Thromb Vasc Biol 2000; 20: 2441–2447
   PubMed Web of Science ®Google Scholar
• Mackness B, Davies GK, Turkie W, Lee E, Roberts DH, Mill E, Roberts C, Durrington PN, Mackness MI. Paraoxonase status in coronary heart disease. Are activity and concentration more important than genotype?. Arterioscler Thromb Vasc Biol 2001; 21: 1461–1467
   Web of Science ®Google Scholar
• Suzuki T, Morito H, Ono K, Mackawa K, Nagai R, Yazaki Y. Sarin poisoning in Tokyo subway. Lancet 1995; 345: 980–981
   PubMed Web of Science ®Google Scholar
• Nagao M, Takatori T, Matsuda Y, Nakajima M, Iwase H, Iwadate K. Definitive evidence for the acute sarin poisoning diagnosis in the Tokyo subway. Toxicol Appl Pharmacol 1997; 144: 198–203
   PubMed Web of Science ®Google Scholar
• Yamasaki Y, Sakamoto K, Watada H, Kajimoto Y, Hori M. The Arg192 isoform of paraoxonase with low sarin-hydrolyzing activity is dominant in the Japanese. Hum Genet 1997; 101: 67–68
   PubMed Web of Science ®Google Scholar
• Yamada Y, Takatori T, Nagao M, Iwase H, Kurada N, Yanagida J, Shinozuka T. Expression of paraoxonase isoform did not confer protection from acute sarin poisoning in the Tokyo subway terrorist attack. Int J Leg Med 2001; 115: 82–84
   PubMed Web of Science ®Google Scholar
• Gulf War and Health. Vol. 1. Depleted Uranium, Pyridostigmine Bromide, Sarin, Vaccines. National Academy Press, Washington, DC 2000; p. 408
   Google Scholar
• Haley RW, Billecke S, La Du BN. Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans. Toxicol Appl Pharmacol 2000; 157: 227–233
   Web of Science ®Google Scholar
• Furlong CE. PON1 status and neurologic symptom complexes in Gulf War Veterans. Gen Res 2000; 10: 153–155
   PubMed Web of Science ®Google Scholar
• Mackness B, Durrington PN, Mackness MI. Low paraoxonase in Persian gulf War veterans self-reporting Gulf War Syndrome. Biochem Biophys Res Commun 2000; 276: 729–733
   PubMed Web of Science ®Google Scholar
• Pilkington A, Buchanan D, Jamal GA, Gillham R, Hansen S, Kidd M, Hurley JF, Soutar CA. An epidemiological study of the relations between exposure to organophosphate pesticides and indices of chronic peripheral neuropathy and neuropsychological abnormalities in sheep farmers and dippers. Occup Environ Med 2001; 58: 702–710
   PubMed Web of Science ®Google Scholar
• Cherry N, Mackness M, Durrington P, Povey A, Dippnal M, Smith T, Mackness B. Paraoxonase (PON1) polymorphisms in farmers attributing ill health to sheep dip. Lancet 2002; 359: 763–764
   PubMed Web of Science ®Google Scholar
• Sozmen EY, Mackness B, Sozmen B, Durrington P, Girgin FK, Aslan L, Mackness M. Effect of organophosphate intoxication on human serum paraoxonase. Hum Exp Toxicol 2002; 21: 247–252
   PubMed Web of Science ®Google Scholar